23G-22 胸腹腔镜食管癌根治术（颈胸结合淋巴结清扫）+盛银良

MIE after Neoadjuvant Immunochemotherapy（with cervical-thoracic & left recurrent laryngeal nerve lymphdenectomy） Authors: Yinliang Sheng M.D, Chunyang Zhang Ph.D, Bin Wu M.D, Ping Yuan Ph.D, Yu Qi Ph.D Minimally invasive esophagectomy after neoadjuvant immunochemotherapy Authors: Yinliang Sheng M.D, Yu Qi Ph.D, Chunyang Zhang Ph.D, Ping Yuan Ph.D，Bin Wu M.D The First Affiliated Hospital of Zhengzhou university Corresponding Author:Yinliang Sheng，1024223908@qq.com,15093145318 Abstract：The application of neoadjuvant immunotherapy and chemotherapy in locally advanced esophageal cancer is feasible, and it can achieve a good preoperative down-stage effect and reduce the risk of palliative and unresectable tumors. After neoadjuvant immunization and chemotherapy, local tissue edema, fibrosis and adhesion of the tissue structure after esophageal tumor regression are acceptable. Modular dissection of lymph nodes is also feasible, the exposure of the surgical field is clear, and the difficulty of the operation is controllable. Some tips for explosion, first is suspend the esophagus, second is Combination of anterior and posterior approach for left bronchus. The hardest part of the surgery is to dissect the lymph nodes around the left RLN, attributing to the anatomy features ,exposing is awkward. Dissection by cervical-thoracic approach is easier and safe, we usually marking the upper thoracic LNs by clip, and then perform in a open way at neck. Conflict of interests: None.

• Category: 2023 Global,Esophageal surgery
• Duration: 12:49
• Date:  8 months ago
• Tags:   2023手术视频大赛+胸腹腔镜食管癌根治术（颈胸结合淋巴结清扫）+盛银良